Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region, has achieved a significant milestone in ...

Thomas E. Hutson, D.O., Pharm.D., Ph.D., chief of the Hematology Oncology Division in the Department of Internal Medicine at ...

Burjeel Holdings has achieved a significant milestone in healthcare education by receiving accreditation from the National ...

New York–based hematologist-oncologist and clinical researcher works to lower the barriers to enrolling in clinical trials.

Hanmi Pharmaceutical confirms positive results for Tibumeshirnon and Keytruda in cancer trial Phase 2 trial highlights ...

In this video, Aruna Padmanabhan, MD, encourages new residents to explore the outpatient treatment landscape and physician ...

FORT MYERS, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Florida Oncology and Hematology, a partner practice of American Oncology Network (AON), has relocated its clinic in Fort Myers to 14551 Hope ...

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

February is Black History Month.Here are some of Healio Women in Oncology’s recent stories that highlight the contributions ...

Nebraska Hematology-Oncology announced a new leader following the retirement of the company’s first CEO. Lisa Jansen, who has a background at Nebraska Medicine, was appointed as the organization ...

Epigenetic alterations have emerged as critical factors in the pathogenesis of brain cancer, particularly gliomas. This article explores the impact of organochlorine pesticides (OCPs) on the ...